It’s Official: FDA Will Now Default to One Clinical Trial for Drug Applications - BioSpace

Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from related indications or animal models.